サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375987

尿路感染症検査の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023-2030年

Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By End Use (Reference Laboratories, General Practitioners, Urologists, Urgent Care), By Region, & Segment Forecasts, 2023-2030
出版日: | 発行: Grand View Research | ページ情報: 英文 113 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
尿路感染症検査の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023-2030年
出版日: 2023年10月20日
発行: Grand View Research
ページ情報: 英文 113 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

尿路感染症検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の尿路感染症検査市場は2030年までに8億1,201万米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 4.4％で成長すると予測されています。尿路感染症（UTI）検査市場は、疾病負担の増加、高齢者人口の増加、急速な技術進歩、自己検査や迅速なPoint-of-Care（PoC）機器製品などの斬新で革新的な製品を導入するための主要企業による高い研究開発投資などの要因によって成長を目の当たりにしています。

尿路感染症は世界的に一般的な関心事となりつつあります。調査によると、尿路感染症は成人女性の5人に1人が一生のうちに一度は発症しています。米国では、20～40歳の女性の約25％～40％が尿路結石症に罹患しています。米国では、毎年約25万件の腎盂腎炎の症例が報告されています。18～19歳の女性では、その発生率は約28/10,000であり、そのうち入院を必要とする症例は7％です。遺伝的および文化的要因がその有病率に影響している可能性があり、例えば韓国では腎盂腎炎の発生率は約59/10,000です。再発率は男性で5.7%、女性で9%であり、他の尿路結石よりも一般的です。

糖尿病患者は急性膀胱炎などの尿路感染症を発症するリスクが高いため、世界の糖尿病有病率の増加が膀胱炎の増加に寄与していると考えられます。NCBIの論文によると、2型糖尿病は尿路結石リスクを上昇させ、2型糖尿病患者は頻繁かつ重症の尿路結石を経験します。2021年の国際糖尿病連合（IDF）のデータによると、2030年までに約6億4,300万人、2045年までに約7億8,300万人が糖尿病に罹患するとされています。さらに、糖尿病女性における無症候性細菌尿の推定有病率は26％であるのに対し、非糖尿病女性では6％です。このような要因により、世界的に膀胱炎の有病率が高まると予想されます。

しかし、このような疾患に対する意識の高まりから、近年は専門医による治療の需要が高まっています。米国保健福祉省によると、米国では2020年の開業泌尿器科医の数は人口10万人当たり4.07人でした。同報告書はさらに、需要の増加により泌尿器科医の不足が観察され、2025年までに3,600人近くの医師を超える可能性があると述べています。これは今後数年間の市場成長を阻害する可能性があります。さらに、COVID-19は業界に悪影響を及ぼしています。尿路結石の患者は、検査や救急医療に大きな支障をきたしています。

主要企業は、ポートフォリオを強化するために新規製品を投入しています。例えば、2021年9月、OpGen, Inc.はUnyvero Urinary Tract Infection Panelの臨床試験開始を発表しました。このパネルは、尿サンプルから直接、広範な病原体と抗菌薬耐性マーカーを分析できます。臨床試験が成功し、このような技術的に先進的かつ効率的な製品が発売されることで、今後数年間の市場成長が見込まれます。同様に、2020年7月、泌尿器の健康バイオテクノロジー企業であるUqora社（Pharmavite, LLC）は、尿路結石診断・管理キットを発売しました。このキットには、PoCや在宅ケアに対応した迅速尿路結石診断装置Clarifyが含まれています。

尿路感染症検査市場のハイライト

  • 膀胱炎が市場を独占し、2022年の推定市場シェアは41.42%に達しました。これは、膀胱炎の罹患率と再発率の高さ、製品承認数の増加、膀胱炎になりやすい糖尿病患者の多さなどに起因します。
  • 参考検査室セグメントは2022年に26.66%のシェアを占めましたが、これは参考検査室が小売レベルで診断施設を提供することで患者の転帰を向上させる努力を続けているためです。
  • 北米は金額ベースで尿路感染症市場全体を支配しました。これは、より良い償還施設と、認知度向上による新規診断製品の採用増加によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 尿路感染症検査市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 尿路感染症検査市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 尿路感染症検査：タイプ別の推定・動向分析

  • 尿路感染症検査市場：重要なポイント
  • 尿路感染症検査市場：動向と市場シェア分析、2022年および2030年
  • 尿道炎
    • 尿道炎市場推計・予測、2018年から2030年まで
  • 膀胱炎
    • 膀胱炎市場推計・予測、2018年から2030年まで
  • 腎盂腎炎
    • 腎盂腎炎市場推計・予測、2018年から2030年まで

第5章 尿路感染症検査：最終用途別の推定・動向分析

  • 尿路感染症検査市場：重要なポイント
  • 尿路感染症検査市場：動向と市場シェア分析、2022年および2030年
  • 一般開業医（GP）
  • 泌尿器科医
  • 泌尿婦人科医
  • 病院検査室
  • 参照検査室
  • 病院の救急部門
  • 緊急処置
  • その他

第6章 尿路感染症検査市場：地域別の推定・動向分析

  • 地域別の展望
  • 尿路感染症検査市場：地域別の重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • QIAGEN
    • Accelerate Diagnostics, Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Siemens Healthcare GmbH
    • Randox Laboratories Ltd.
    • Thermo Fisher Scientific, Inc.
    • BIOMERIEUX
    • T2 Biosystems, Inc.
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 17 France urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 31 China urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 China urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 36 India urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Thailand urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Thailand urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Latin America urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 42 Latin America urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Brazil urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Brazil urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Mexico urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 47 Mexico urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Argentina urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 49 Argentina urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Middle East and Africa urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 Middle East and Africa urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 53 South Africa urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 South Africa urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Saudi Arabia urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 57 UAE urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 58 UAE urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Kuwait urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 Kuwait urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Urinary tract infection testing: Market outlook
  • Fig. 9 Urinary tract infection testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Urinary tract infection testing market driver impact
  • Fig. 15 Urinary tract infection testing market restraint impact
  • Fig. 16 Urinary tract infection testing market strategic initiatives analysis
  • Fig. 17 Urinary tract infection testing market: Type movement analysis
  • Fig. 18 Urinary tract infection testing market: Type outlook and key takeaways
  • Fig. 19 Urethritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cystitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Pyelonephritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Urinary tract infection testing market: End use movement analysis
  • Fig. 23 Urinary tract infection testing market: End use outlook and key takeaways
  • Fig. 24 General practitioners (GPs) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Urologists market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Urogynecologists market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hospital laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Reference laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Hospital emergency departments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Urgent care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global urinary tract infection testing market: Regional movement analysis
  • Fig. 33 Global urinary tract infection testing market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-951-8

Urinary Tract Infection Testing Market Growth & Trends:

The global urinary tract infection testing market is expected to reach USD 812.01 million by 2030, according to a new report by Grand View Research, Inc.. The market is anticipated to grow at a CAGR of 4.4% from 2023 to 2030. The urinary tract infection (UTI) testing market is witnessing growth due to factors such as rising disease burden, increasing geriatric population, rapid technological advancements, and high R&D investments by key players to introduce novel & innovative products, such as self-testing & rapid Point-of-Care (PoC) devices products.

Urinary tract infection is becoming a common global concern. According to research studies, UTI occurs in one in five adult women at some point in their life. In the U.S., about 25%-40% of women aged 20-40 have suffered a UTI. In the U.S., about 250,000 cases of pyelonephritis are reported every year. In women aged 18-19, its incidence is about 28/10,000, out of which 7% of cases require hospital admission. Genetic and cultural factors may influence its prevalence; for instance, in South Korea, the incidence of pyelonephritis is around 59/10,000. Its recurrence is more common than other UTIs, with the recurrence rate being 5.7% in men and 9% in women.

Patients with diabetes are at increased risk of developing urinary tract infections such as acute cystitis, and therefore, the increasing global prevalence of diabetes is likely to contribute to cystitis growth. According to an NCBI article, type 2 diabetes raises UTI risk and patients with type 2 diabetes experience frequent & severe UTIs. According to the International Diabetes Federation (IDF) data from 2021, approximately 643 million individuals will have diabetes by 2030 and 783 million by 2045. Moreover, the estimated prevalence of asymptomatic bacteriuria in diabetic females is 26%, compared to 6% in nondiabetic females. Such factors are expected to boost the prevalence of cystitis globally.

However, due to the rise in awareness about such diseases, the demand for specialist treatment has increased in recent years. According to the U.S. Department of Health and Human Services, in the U.S., the number of practicing urologists in 2020 was 4.07 per 100,000 populations. The report further stated that due to the rise in demand, a shortage of urologists was observed, which is likely to exceed nearly 3,600 physicians by 2025. This can impede market growth in the coming years. Moreover, COVID-19 has had a detrimental impact on the industry. Individuals with UTIs have experienced substantial disruptions in testing and emergency care.

Key players are introducing novel products to strengthen their portfolios. For instance, in September 2021, OpGen, Inc. announced initiating clinical trials of the Unyvero Urinary Tract Infection Panel. The panel can analyze a broad range of pathogens and antimicrobial resistance markers directly from a urine sample. Successful clinical trials and the launch of such technologically advanced & efficient products are anticipated to drive market growth over the coming years. Similarly, in July 2020, Uqora, Inc. (Pharmavite, LLC), a urinary health biotechnology company, launched a UTI diagnostic and management kit. The kit includes a rapid UTI diagnostic device, Clarify, compatible with a PoC and homecare setting.

Urinary Tract Infection Testing Market Highlights

  • Cystitis dominated the market in 2022, with an estimated market share of 41.42%. This can be attributed to the high incidence & recurrence rate of cystitis, increased number of product approvals, and the high number of diabetes patients who are more prone to cystitis
  • The reference laboratories segment held a share of 26.66% in 2022 attributed to the ongoing efforts of reference laboratories to enhance patient outcomes by offering diagnostic facilities at retail level.
  • North America dominated the overall urinary tract infection market in terms of value. This can be attributed to better reimbursement facilities and a rise in the adoption of novel diagnostic products due to increased awareness

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Urinary Tract Infection Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Urinary Tract Infection Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Urinary Tract Infection Testing: Type Estimates & Trend Analysis

  • 4.1. Urinary Tract Infection Testing Market: Key Takeaways
  • 4.2. Urinary Tract Infection Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Urethritis
    • 4.3.1. Urethritis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Cystitis
    • 4.4.1. Cystitis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Pyelonephritis
    • 4.5.1. Pyelonephritis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Urinary Tract Infection Testing: End Use Estimates & Trend Analysis

  • 5.1. Urinary Tract Infection Testing Market: Key Takeaways
  • 5.2. Urinary Tract Infection Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. General Practitioners (GPs)
    • 5.3.1. General practitioners (GPs) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Urologists
    • 5.4.1. Urologists market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Urogynecologists
    • 5.5.1. Urogynecologists market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Hospital Laboratories
    • 5.6.1. Hospital laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Reference Laboratories
    • 5.7.1. Reference laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Hospital Emergency Departments
    • 5.8.1. Hospital emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Urgent Care
    • 5.9.1. Urgent care market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Urinary Tract Infection Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Urinary Tract Infection Testing Market by Region: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. QIAGEN
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Accelerate Diagnostics, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Bio-Rad Laboratories, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. F. Hoffmann-La Roche Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Danaher
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Siemens Healthcare GmbH
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Randox Laboratories Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Thermo Fisher Scientific, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. BIOMERIEUX
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. T2 Biosystems, Inc.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives